Evidence review

VIP for Diabetic Neuropathy: Evidence-Graded Overview

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `vip-diabetic-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/vip-diabetic-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-diabetic-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-diabetic-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-diabetic-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-diabetic-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Diabetic neuropathy

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why VIP might help you

  1. You are reading about Diabetic neuropathy — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • VIP → immune / autonomic

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 2

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.33 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

The effects of vasoactive intestinal polypeptide and substance P on the cutaneous nerves of diabetic patients with peripheral neuropathy (source s1)

1995 study showing reduced VIP in diabetic neuropathy skin nerves.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Vasoactive Intestinal Peptide and Nerve Regeneration (source s2)

Rat study on VIP changes during nerve regeneration.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Neuropathy (general) · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpVIP for Statin-Associated Cognitive Effects: Evidence Review · 2 humanVIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomi… · 2 humanVIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Review · 2 humanVIP for Frozen Shoulder: Evidence Review · 2 human
Evidence · 2 sources · swipe →chain 2959a7186518 · verify chain · provenance
1 / 2
Evidence ledger 3 · tier-ranked · API
human
VIP immunoreactivity is reduced in cutaneous nerves of diabetic patients with peripheral neuropathy.
sources: s1
human
No randomized controlled human trials exist for VIP in diabetic neuropathy treatment.
preclinicallow confidence
VIP levels change during nerve regeneration in a rat model.
sources: s2
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:32
VIP for Diabetic Neuropathy: Evidence-Graded Overview · 3 claims · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Vip for Diabetic Neuropathy
Slug: vip-diabetic-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Diabetic neuropathy","condition_key":"diabetic-neuropathy","primary_peptide":"vip","peptides_in_scope":[{"id":"vip","name":"VIP"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking
it output
{
  "slug": "vip-diabetic-neuropathy",
  "title": "VIP for Diabetic Neuropathy: Evidence-Graded Overview",
  "body": "## What's breaking down if you have Diabetic neuropathy\n\nDiabetic neuropathy involves progressive nerve fiber damage linked to chronic high blood sugar. Layers include axonal degeneration, reduced nerve blood flow, immune activation in nerves, and autonomic imbalance. These processes shift the balance toward breakdown outrunning repair in peripheral nerves.\n\n## Why VIP might help you\n\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\n2. **Therefore for you:** If the immune / autonomic layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP has been studied for effects on nerve tissue repair pathways and autonomic signaling. If immune modulation or autonomic support aligns with the layers affected in your case, that forms the basis for discussion.\n\n## How these fit together\n\nSingle-compound focus. VIP targets the immune / autonomic layer listed in the condition profile.\n\n## What the evidence actually shows\n\nHuman data: One 1995 study measured VIP immunoreactivity in skin biopsies from diabetic patients with peripheral neuropathy and found reduced VIP levels in cutaneous nerves compared to controls (human observational). No randomized h
6ade25eface3cc46

Related research

Neuropathy (general) · condition map

Open evidence map →
VipvipVIP for Benzodiazepine Withdrawal: Evidence Reviewvip-benzo-withdrawalVIP and Benzodiazepines: Immune and Autonomic Pathways in a Suppressio…vip-benzodiazepinesVIP for Statin-Associated Cognitive Effects: Evidence Reviewvip-brain-fogVIP for Carpal Tunnel Syndrome: A Data-First Evidence Reviewvip-carpal-tunnelVIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomi…vip-chemoVIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Reviewvip-chemo-neuropathyVIP for Cognition: Evidence on Vasoactive Intestinal Peptidevip-cognitionVIP and Corticosteroid Injections: Evidence Layers on Immune Modulatio…vip-corticosteroidsVIP for Frozen Shoulder: Evidence Reviewvip-frozen-shoulder
Ask this article · 5 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "VIP immunoreactivity is reduced in cutaneous nerves of diabetic patients with peripheral neuropathy."?
ask vip-diabetic-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No randomized controlled human trials exist for VIP in diabetic neuropathy treatment."?
ask vip-diabetic-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP levels change during nerve regeneration in a rat model."?
ask vip-diabetic-neuropathy claim c2 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about VIP for Diabetic Neuropathy: Evidence-Graded Overview — and what would you need me to tell you first?
ask vip-diabetic-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for VIP for Diabetic Neuropathy: Evidence-Graded Overview (studies vs anecdotes)?
ask vip-diabetic-neuropathy good bad experiences · paste includes §SELF
vip-diabetic-neuropathy · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 16236 tokens · $0 · 1 model
chain head 0199b89305b21b00
write grok/grok-4.3 · 2026-06-29 22:32 · 16236 tok · 0199b89305b2
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 22:33 · t_8la90g91
PROTOCOL_RUN dispatch · 2026-06-29 22:33 · t_8la90g91
webhook_in blooio · 2026-06-29 22:33
webhook_in blooio · 2026-06-29 22:32
webhook_in blooio · 2026-06-29 22:32
webhook_in blooio · 2026-06-29 22:32
view full ledger & cards →
REST + ledger
read GET /api/articles/vip-diabetic-neuropathy · GET /api/articles/vip-diabetic-neuropathy?format=post (the editable body)
create/replace POST /api/articles/vip-diabetic-neuropathy · PUT /api/articles/vip-diabetic-neuropathy (replace, keeps revision) · PATCH /api/articles/vip-diabetic-neuropathy (merge)
delete DELETE /api/articles/vip-diabetic-neuropathy
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/vip-diabetic-neuropathy/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/vip-diabetic-neuropathy/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim vip-diabetic-neuropathy|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →